Usa India virus covid-19 SARS-CoV-2 Usa India

IISC scientists say Asthama drug Montelukast can reduce Covid virus from replicating. Read here

Reading now: 564
www.livemint.com

SARS-CoV-2 infection." Montelukast, used to reduce inflammation caused by conditions like asthma, hay fever and hives, has been found effective against Covid-19.

The drug has the potential to reduce SARS-CoV-2, the virus that causes Covid-19, from replicating in human immune cells, the study revealed.

Researchers at the IISc found that the drug binds strongly to one end (‘C-terminal’) of a SARS-CoV-2 protein called Nsp1, which is one of the first viral proteins unleashed inside human cells.

This protein can bind to ribosomes the protein-making machinery inside our immune cells and shut down the synthesis of vital proteins required by the immune system, thereby weakening it.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA